In a two-factor ANOVA, always test for interaction last. Indicate whether the statement is true or ...

Author Question: In a two-factor ANOVA, always test for interaction last. Indicate whether the statement is true or ... (Read 99 times)

sabina

Hero Member
Posts: 563

on: Jun 24, 2018

In a two-factor ANOVA, always test for interaction last.
Indicate whether the statement is true or false

Question 2

When the purpose of sampling is to detect when a process becomes too variable, the control chart of choice will be an S chart.
Indicate whether the statement is true or false

Koolkid240

Sr. Member
Posts: 357

Reply #1 on: Jun 24, 2018

Answer to Question 1

F

Answer to Question 2

F

Need homework help now?

Ask unlimited questions for free

Ask a Question

« previous next »

Did you know?

People often find it difficult to accept the idea that bacteria can be beneficial and improve health. Lactic acid bacteria are good, and when eaten, these bacteria improve health and increase longevity. These bacteria included in foods such as yogurt.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

A headache when you wake up in the morning is indicative of sinusitis. Other symptoms of sinusitis can include fever, weakness, tiredness, a cough that may be more severe at night, and a runny nose or nasal congestion.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.